Effects of nefopam on catheter-related bladder discomfort in patients undergoing ureteroscopic litholapaxyopen access
- Authors
- Cheon, Yong Woo; Kim, Seon Hwan; Paek, Jin Hyub; Kim, Jin A.; Lee, Yong Kyung; Min, Jin Hye; Cho, Hyung Rae
- Issue Date
- Jun-2018
- Publisher
- Korean Society of Anesthesiologists
- Keywords
- Complications; Nefopam; Ureteroscopy; Urinary catheterization
- Citation
- Korean Journal of Anesthesiology, v.71, no.3, pp 201 - 206
- Pages
- 6
- Indexed
- SCOPUS
ESCI
KCI
- Journal Title
- Korean Journal of Anesthesiology
- Volume
- 71
- Number
- 3
- Start Page
- 201
- End Page
- 206
- URI
- https://scholarworks.bwise.kr/hanyang/handle/2021.sw.hanyang/190811
- DOI
- 10.4097/kja.d.18.27113
- ISSN
- 2005-6419
2005-7563
- Abstract
- Background: Patients who undergo urinary catheterization may experience postoperative catheter-related bladder discomfort (CRBD). Previous studies have indicated that drugs with antimuscarinic effects could reduce the incidence and severity of CRBD. Accordingly, this study was carried out to investigate whether nefopam, a centrally acting analgesic with concomitant antimuscarinic effect, reduces the incidence and severity of CRBD. Methods: Sixty patients with American Society of Anesthesiologists physical status I and II and aged 18–70 years who were scheduled to undergo elective ureteroscopic litholapaxy participated in this double-blinded study. Patients were divided into control and nefopam groups, comprising 30 patients each. In the nefopam group, 40 mg nefopam in 100 ml of 0.9% saline was administered intravenously. In the control group, only 100 ml of 0.9% saline was administered. All patients had a urethral catheter and ureter stent inserted during surgery. The incidence and severity of CRBD, numerical rating scale (NRS) score of postoperative pain, rescue pethidine dose, and side effects were recorded in the post-anesthesia care unit after surgery. Results: The incidence (P = 0.020) and severity (P <0.001) of CRBD were significantly different between the control group and the nefopam group. The NRS score of postoperative pain (P = 0.006) and rescue dose of pethidine (P < 0.001) were significantly higher in the control group than in the nefopam group. Conclusions: Intravenous administration of nefopam in patients scheduled to undergo ureteroscopic litholapaxy reduced the incidence and severity of CRBD, NRS score of postoperative pain and analgesic requirements.
- Files in This Item
-
- Appears in
Collections - 서울 의과대학 > 서울 교육협력지원교실 > 1. Journal Articles
![qrcode](https://api.qrserver.com/v1/create-qr-code/?size=55x55&data=https://scholarworks.bwise.kr/hanyang/handle/2021.sw.hanyang/190811)
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.